BFlow is excited to announce its participation in the 1st SESMOoC conference, taking place on November 24 in Zaragoza. This landmark event, organized by the Spanish Society of Microphysiological Systems and Organ-on-Chip (SESMOoC), represents a major step forward for the Organ-on-Chip community in Spain, bringing visibility, cohesion and momentum to an emerging field with enormous potential.

As pioneers committed to transforming preclinical research, BFlow will be represented by our general manager, Enrique Sánchez and our biological validation specialist, Andrea Balsa, who will actively participate in the sessions and discussions alongside leading researchers, start-ups and industry partners.

We are especially proud to share that BFlow has been selected to participate in the oral communications, a recognition that highlights the relevance of our work and the impact that our technology is having in the scientific and industrial ecosystem. During this session, we will present how BFlow is helping research teams increase reproducibility, reduce variability and gain more physiologically relevant insights in early drug development.

The SESMOoC conference marks an important milestone for the Organ-on-Chip community, offering a space for dialogue, training and innovation. At BFlow, we believe that progress happens when technology and science move forward together. That’s why we work to develop user-friendly, scalable and impactful solutions that empower researchers to make better decisions, earlier, faster and with greater confidence. By joining this inaugural meeting, BFlow strengthens its commitment to the scientific community and continues to build strategic relationships that will drive the next generation of biomedical tools across Spain and beyond.

We look forward to connecting with colleagues, learning from the community and contributing to the collective effort of shaping the future of biomedical research in Spain.

As pioneers committed to transforming preclinical research, BFlow will be represented by our general manager, Enrique Sánchez and our biological validation specialist, Andrea Balsa, who will actively participate in the sessions and discussions alongside leading researchers, start-ups and industry partners.

We are especially proud to share that BFlow has been selected to participate in the oral communications, a recognition that highlights the relevance of our work and the impact that our technology is having in the scientific and industrial ecosystem. During this session, we will present how BFlow is helping research teams increase reproducibility, reduce variability and gain more physiologically relevant insights in early drug development.

The SESMOoC conference marks an important milestone for the Organ-on-Chip community, offering a space for dialogue, training and innovation. At BFlow, we believe that progress happens when technology and science move forward together. That’s why we work to develop user-friendly, scalable and impactful solutions that empower researchers to make better decisions, earlier, faster and with greater confidence. By joining this inaugural meeting, BFlow strengthens its commitment to the scientific community and continues to build strategic relationships that will drive the next generation of biomedical tools across Spain and beyond.

We look forward to connecting with colleagues, learning from the community and contributing to the collective effort of shaping the future of biomedical research in Spain.